Company: Sienna Biopharmaceuticals
Job title: CSO
Silvio was born in Ivrea (Italy) on November 25, 1969. He was granted a Degree in Chemistry in 1994, and a PhD in protein Chemistry in 1998.
Silvio joined Serono (Drug Delivery Systems unit) in 1999, where he eventually became Head of the Protein Analysis and Peptide Synthesis Lab. In 2005, he joined Creabilis as Head of Discovery, and then Chief Scientific Officer.
In 2010, Silvio attended the ‘Leadership and Strategy in Pharmaceuticals and Biotech’ at the Harvard Business School. Silvio is currently CSO at Sienna Biopharmaceuticals, which he joined in 2016 after the acquisition of Creabilis by Sienna on Dec 6, 2016.
The Topical-by-Design Technology – Defying Conventional Wisdom 9:30 am
• Does size really matter? • Exploring an innovative way of using polymers • Bringing potent drugs to derm fruition, minimizing systemic exposureRead more
day: Day Two
Opening Keynote Panel Discussion: What’s Next in Dermatology Drug Development? 9:00 am
• Establishing the current landscape and state-of-the art in dermatology drug development – latest advances and challenges • Lessons learned for rational and effective drug development in dermatology – discussing a ‘blueprint’ of what success looks like in dermatology drug development • Analysing the end-to-end pain points that accompany dermatology programs – from improving preclinical…Read more
day: Day One